Responses
Regular Abstracts – Part 2
Clinical Trial In Progress
782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update
Compose a Response to This Article
Other responses
No responses have been published for this article.
